Inflammation-sensitive plasma proteins and incidence of myocardial infarction in men with low cardiovascular risk

被引:45
作者
Engström, G
Stavenow, L
Hedblad, B
Lind, P
Tydén, P
Janzon, L
Lindgärde, F
机构
[1] Malmo Univ Hosp, Dept Community Med, S-20502 Malmo, Sweden
[2] Malmo Univ Hosp, Dept Internal Med, S-20502 Malmo, Sweden
[3] Malmo Univ Hosp, Dept Vasc Dis, S-20502 Malmo, Sweden
[4] Malmo Univ Hosp, Dept Cardiol, S-20502 Malmo, Sweden
关键词
myocardial infarction; inflammation; epidemiology; risk factors;
D O I
10.1161/01.ATV.0000102924.11767.8D
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Myocardial infarction (MI) is sometimes experienced by individuals without any traditional risk factor. This prospective study explored whether incidence of MI in nonsmoking, nondiabetic men with normal blood pressure and serum lipids is related to inflammation-sensitive plasma proteins (ISPs). Methods and Results - Five ISPs (alpha1-antitrypsin, haptoglobin, ceruloplasmin, fibrinogen, orosomucoid) were analyzed in 6075 men, 47 +/- 3.6 years old. A low-risk group (no traditional risk factor, n = 1108) and a high-risk group (greater than or equal to2 major risk factors, n = 1011) were defined. Incidence of MI (n = 227) was monitored over 18.1 +/- 4.3 years of follow-up. In the low-risk group, the age-adjusted relative risks (RRs) were 1.00 (reference), 1.9 (95% CI, 0.8 to 4.2), 1.8 (95% CI, 0.6 to 5.4), and 2.9 (95% CI, 1.05 to 8.1), respectively, for men with 0, 1, 2 and greater than or equal to 3 ISPs in the top quartile (trend: P = 0.03). In this group, the increased risk was observed only after greater than or equal to 10 years of follow-up. In the high-risk group, the age-adjusted RRs were 1.00, 1.4 (95% CI, 0.9 to 2.2), 1.9 (95% CI, 1.2 to 3.1), and 2.0 ( 95% CI, 1.3 to 3.1), respectively, for men with 0, 1, 2, and greater than or equal to 3 ISPs in the top quartile (trend: P = 0.0004). Conclusion - Incidence of MI in nonsmoking, nondiabetic men with normal blood pressure and lipids was related to ISPs. The causes for this relationship remain to be explored.
引用
收藏
页码:2247 / 2251
页数:5
相关论文
共 32 条
  • [21] National Board of Health and Welfare, 2000, VARD DIAGN AK HJART
  • [22] C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
    Pradhan, AD
    Manson, JE
    Rifai, N
    Buring, JE
    Ridker, PM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (03): : 327 - 334
  • [23] Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
    Ridker, PM
    Cushman, M
    Stampfer, MJ
    Tracy, RP
    Hennekens, CH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14) : 973 - 979
  • [24] ROSCHLAU P, 1974, Z KLIN CHEM KLIN BIO, V12, P403
  • [25] Mechanisms of disease - Atherosclerosis - An inflammatory disease
    Ross, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (02) : 115 - 126
  • [26] C-reactive protein and myocardial infarction
    Sakkinen, P
    Abbott, RD
    Curb, JD
    Rodriguez, BL
    Yano, K
    Tracy, RP
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2002, 55 (05) : 445 - 451
  • [27] *SPSS INC, 1997, SPSS ADV STAT 7 5
  • [28] Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy - Findings for 5 large cohorts of young adult and middle-aged men and women
    Stamler, J
    Stamler, R
    Neaton, JD
    Wentworth, D
    Daviglus, ML
    Garside, D
    Dyer, AR
    Liu, KA
    Greenland, P
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21): : 2012 - 2018
  • [29] Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes
    Stefanadis, C
    Diamantopoulos, L
    Dernellis, J
    Economou, E
    Tsiamis, E
    Toutouzas, K
    Vlachopoulos, C
    Toutouzas, P
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (01) : 43 - 52
  • [30] C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly
    Strandberg, TE
    Tilvis, RS
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (04) : 1057 - 1060